Diabetes in pregnancy (CG63)
Fast, easy summary view of NICE guidance on 'diabetes in pregnancy'
Specific, concise statements that act as markers of high-quality, cost-effective patient care
Diabetes in pregnancy: management of diabetes and its complications from pre-conception to the postnatal period
This guidance covers the care and treatment of pregnant women with diabetes in the NHS in England and Wales. It also covers the care of their newborn babies. It is written for women who have diabetes or develop it in pregnancy, but it may also be useful for their families or for anyone with an interest in the condition.
July 2008: Since publication, the information on the therapeutic indications, contraindications and use in pregnancy and lactation of drugs used in diabetes management and retinal assessment (specifically insulins, the oral hypoglycaemic agents metformin and glibenclamide, and tropicamide) has been corrected to follow the relevant summaries of product characteristics (SPCs) (July 2008). Changes have been made to the NICE guideline, the full guideline and the quick reference guide.
'The recommendation on the use of the rapid-acting insulin analogues aspart and lispro in pregnant women with diabetes (this is recommendation 18.104.22.168 in the NICE guideline) is now as follows:
Healthcare professionals should be aware that data from clinical trials and other sources do not suggest that the rapid-acting insulin analogues (aspart and lispro) adversely affect the pregnancy or the health of the fetus or newborn baby.
The electronic versions of the guideline on this website all contain the correct information on drugs used in diabetes management and retinal assessment. Hard copies of the corrected quick reference guide are being mailed to the NHS.
The Understanding NICE guidance booklet does not give all details of the information healthcare professionals need to consider when prescribing insulin and other drugs used to manage diabetes or for retinal assessment in women who are pregnant or breastfeeding. Therefore it did not require any changes to reflect the reissued guideline on diabetes in pregnancy and has not been reissued.
- CG63 Diabetes in pregnancy: full guideline, search strategies
- CG63 Diabetes in pregnancy: full guideline, evidence tables
- CG63Diabetes in pregnancy: NICE guideline (web format)
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: diabetes in pregnancy
This page was last updated: 08 May 2013
- Web format
- Quick reference guide (PDF)
- NICE Guideline (PDF)
- Full Guideline (PDF)
- CG63: Diabetes yn ystod beichiogrwydd: deall canllawiau NICE (fformat MS Word)
Information for the public
Consultation on review proposal with stakeholders: 07 March 2011 - 20 March 2011
Review decision date: May 2011
This guideline is currently being updated. Further information can be found on the Diabetes in pregnancy guideline in development page.
Implementation tools and resources
- Audit support
- Costing report
- Costing template
- Slide set
- Complications in pregnancy: online educational tool
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guideline, contains the recommendations for health professionals and NHS bodies.
The published full clinical guideline for specialists with background, evidence, recommendations and methods used.